Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

MG Espey, P Chen, B Chalmers, J Drisko… - Free Radical Biology …, 2011 - Elsevier
Conventional treatment approaches have had little impact on the course of pancreatic
cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary …
被引用次数：217 相关文章

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

MG Espey, P Chen, B Chalmers, J Drisko… - Free Radical Biology …, 2011 - europepmc.org
Conventional treatment approaches have had little impact on the course of pancreatic
cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary …

[引用][C] Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

MG Espey, P Chen, B Chalmers, J Drisko… - Free Radical Biology …, 2011 - cir.nii.ac.jp
Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[PDF] researchgate.net

[PDF][PDF] Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

M Levine, Q Chen - Free Radical Biology & Medicine, 2011 - researchgate.net
Michael Graham Espey a, Ping Chen b, c, Brian Chalmers b, Jeanne Drisko b, Andrew Y.
Sun a, Mark Levine a, Qi Chen b,⁎ a Molecular and Clinical Nutrition Section, National …

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

MG Espey, P Chen, B Chalmers, J Drisko… - Free Radical Biology …, 2011 - infona.pl
Conventional treatment approaches have had little impact on the course of pancreatic
cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary …

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

MG Espey, P Chen, B Chalmers… - … radical biology & …, 2011 - pubmed.ncbi.nlm.nih.gov
Conventional treatment approaches have had little impact on the course of pancreatic
cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary …
[HTML] nih.gov

[HTML][HTML] Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

MG Espey, P Chen, B Chalmers, J Drisko… - Free radical biology & …, 2011 - ncbi.nlm.nih.gov
Conventional treatment approaches have had little impact on the course of pancreatic
cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary …

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

MG Espey, P Chen, B Chalmers, J Drisko… - Free Radical Biology …, 2011 - europepmc.org
Conventional treatment approaches have had little impact on the course of pancreatic
cancer, which has the highest fatality rate among cancers. Gemcitabine, the primary …
[PDF] researchgate.net

[PDF][PDF] Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

M Levine, Q Chen - Free Radical Biology & Medicine, 2011 - researchgate.net
Michael Graham Espey a, Ping Chen b, c, Brian Chalmers b, Jeanne Drisko b, Andrew Y.
Sun a, Mark Levine a, Qi Chen b,⁎ a Molecular and Clinical Nutrition Section, National …